197 related articles for article (PubMed ID: 19496239)
1. Dasatinib: for some difficult cases of adult leukaemia.
Prescrire Int; 2008 Aug; 17(96):149-50. PubMed ID: 19496239
[No Abstract] [Full Text] [Related]
2. Dasatinib.
Kantarjian H; Jabbour E; Grimley J; Kirkpatrick P
Nat Rev Drug Discov; 2006 Sep; 5(9):717-8. PubMed ID: 17001803
[No Abstract] [Full Text] [Related]
3. Dasatinib (Sprycel) for CML and Ph + ALL.
Med Lett Drugs Ther; 2007 Jan; 49(1252):6-7. PubMed ID: 17220814
[No Abstract] [Full Text] [Related]
4. [Dasatinib. A novel tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia].
Bjerrum OW; Dufva IH; Stentoft J; Hasselbalch HC
Ugeskr Laeger; 2008 Jan; 170(5):331-3. PubMed ID: 18252160
[TBL] [Abstract][Full Text] [Related]
5. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure.
Sonmez M; Cobanoglu U; Ovali E; Omay SB
J Clin Pharm Ther; 2008 Jun; 33(3):329-30. PubMed ID: 18452422
[No Abstract] [Full Text] [Related]
6. New approved dasatinib regimen available for clinical use.
Snyder DS
Expert Rev Anticancer Ther; 2009 Mar; 9(3):285-92. PubMed ID: 19275507
[TBL] [Abstract][Full Text] [Related]
7. Pleural effusions due to dasatinib.
Brixey AG; Light RW
Curr Opin Pulm Med; 2010 Jul; 16(4):351-6. PubMed ID: 20375898
[TBL] [Abstract][Full Text] [Related]
8. Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.
Soverini S; Martinelli G; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M
J Clin Oncol; 2006 Nov; 24(33):e51-2. PubMed ID: 17114651
[No Abstract] [Full Text] [Related]
9. Dasatinib, a multikinase inhibitor: therapy, safety, and appropriate management of adverse events.
Shayani S
Ther Drug Monit; 2010 Dec; 32(6):680-7. PubMed ID: 20864900
[TBL] [Abstract][Full Text] [Related]
10. Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.
Caocci G; Atzeni S; Orrù N; Azzena L; Martorana L; Littera R; Ledda A; La Nasa G
Leukemia; 2008 Nov; 22(11):2127-8. PubMed ID: 18463676
[No Abstract] [Full Text] [Related]
11. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib.
Oweini H; Otrock ZK; Mahfouz RA; Bazarbachi A
Arch Gynecol Obstet; 2011 Jan; 283(1):133-4. PubMed ID: 20473616
[TBL] [Abstract][Full Text] [Related]
12. Imatinib: a second look. Longer follow-up in chronic myeloid leukaemia: clear advantages.
Prescrire Int; 2008 Dec; 17(98):226-8. PubMed ID: 19415889
[TBL] [Abstract][Full Text] [Related]
13. Dasatinib-induced pleural effusions: a lymphatic network disorder?
Goldblatt M; Huggins JT; Doelken P; Gurung P; Sahn SA
Am J Med Sci; 2009 Nov; 338(5):414-7. PubMed ID: 19838099
[TBL] [Abstract][Full Text] [Related]
14. Dasatinib and chronic myeloid leukemia: two-year follow-up in eight clinical trials.
Pavlů J; Marin D
Clin Lymphoma Myeloma; 2009 Dec; 9(6):417-24. PubMed ID: 19951880
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for the management of dasatinib (Sprycel)-induced side effects in chronic myelogenous leukemia and Philadelphia positive acute lymphoblastic leukemias].
Cony-Makhoul P; Bergeron A; Corm S; Dubruille V; Rea D; Rigal-Huguet F; Nicolini FE
Bull Cancer; 2008 Sep; 95(9):805-11. PubMed ID: 18829412
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib-induced lupus.
Rea D; Bergeron A; Fieschi C; Bengoufa D; Oksenhendler E; Dombret H
Lancet; 2008 Aug; 372(9640):713-4. PubMed ID: 18761212
[No Abstract] [Full Text] [Related]
17. Imatinib: new indication. New indications, but not robust evidence.
Prescrire Int; 2008 Jun; 17(95):91-4. PubMed ID: 18623899
[TBL] [Abstract][Full Text] [Related]
18. Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia.
Lee SJ; Jung CW; Kim DY; Lee KH; Sohn SK; Kwak JY; Kim HJ; Kim IH; Park S; Kim DH
Am J Hematol; 2011 Apr; 86(4):346-50. PubMed ID: 21442637
[TBL] [Abstract][Full Text] [Related]
19. The FDA approves new leukemia drug; expands use of current drug.
FDA Consum; 2006; 40(6):5. PubMed ID: 17338066
[No Abstract] [Full Text] [Related]
20. Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy.
Eskazan AE; Hatemi İ; Öngören Aydın S; Ar MC; Soysal T
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():233. PubMed ID: 25910316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
